BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lei WY, Wang JH, Yi CH, Liu TT, Hung JS, Wong MW, Bair MJ, Vaezi MF, Orr WC, Chen CL. Association between use of proton pump inhibitors and colorectal cancer: A nationwide population-based study. Clin Res Hepatol Gastroenterol 2021;45:101397. [PMID: 32224118 DOI: 10.1016/j.clinre.2020.02.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Orel R, Benninga MA, Broekaert IJ, Gottrand F, Papadopoulou A, Ribes-Koninckx C, Thomson M, Wilschanski M, Thapar N. Drugs in Focus: Proton Pump Inhibitors. J Pediatr Gastroenterol Nutr 2021;72:645-53. [PMID: 33847286 DOI: 10.1097/MPG.0000000000003063] [Reference Citation Analysis]
2 Ma T, Wu M, Jia S, Yang L. Proton pump inhibitors and the risk of colorectal cancer: a systematic review and meta-analysis of observational studies. Int J Colorectal Dis 2020;35:2157-69. [DOI: 10.1007/s00384-020-03717-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
3 Koulouridi A, Messaritakis I, Gouvas N, Tsiaoussis J, Souglakos J. Immunotherapy in Solid Tumors and Gut Microbiota: The Correlation-A Special Reference to Colorectal Cancer. Cancers (Basel) 2020;13:E43. [PMID: 33375686 DOI: 10.3390/cancers13010043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zeng R, Cheng Y, Luo D, Wang J, Yang J, Jiang L, Zhuo Z, Guo K, Wu H, Leung FW, Sha W, Chen H. Comprehensive analysis of proton pump inhibitors and risk of digestive tract cancers. Eur J Cancer 2021;156:190-201. [PMID: 34481369 DOI: 10.1016/j.ejca.2021.07.030] [Reference Citation Analysis]
5 Kawada T. Proton pump inhibitors and the risk of colorectal cancer. Clin Res Hepatol Gastroenterol 2021;45:101730. [PMID: 34129930 DOI: 10.1016/j.clinre.2021.101730] [Reference Citation Analysis]
6 Yang XM, Xu H. Clinical features of fundic gland polyps and their correlation with colorectal tumors. Shijie Huaren Xiaohua Zazhi 2020; 28(20): 1036-1041 [DOI: 10.11569/wcjd.v28.i20.1036] [Reference Citation Analysis]
7 Qin BD, Jiao XD, Zhou XC, Shi B, Wang J, Liu K, Wu Y, Ling Y, Zang YS. Effects of concomitant proton pump inhibitor use on immune checkpoint inhibitor efficacy among patients with advanced cancer. Oncoimmunology 2021;10:1929727. [PMID: 34350061 DOI: 10.1080/2162402X.2021.1929727] [Reference Citation Analysis]
8 Patel A, Spychalski P, Antoszewska M, Regula J, Kobiela J. Proton pump inhibitors and colorectal cancer: A systematic review. World J Gastroenterol 2021; 27(44): 7716-7733 [PMID: 34908809 DOI: 10.3748/wjg.v27.i44.7716] [Reference Citation Analysis]
9 Abrahami D, McDonald EG, Schnitzer ME, Barkun AN, Suissa S, Azoulay L. Proton pump inhibitors and risk of colorectal cancer. Gut 2021:gutjnl-2021-325096. [PMID: 34210775 DOI: 10.1136/gutjnl-2021-325096] [Reference Citation Analysis]